Biopharmaceutical Company Seeks Review Of Objective Indicia Of Nonobviousness
WASHINGTON, D.C. — An appellate court incorrectly disregarded objective indicia of nonobviousness that clearly apply to the claimed patent invention, a biopharmaceutical company argues in a March 28 petition seeking review...To view the full article, register now.
Already a subscriber? Click here to view full article